Biopharmaceuticals
- Market
Upbeat result of COVID-19 vaccine trial in 5- to 11-year-olds tempered as U.S. daily death rate tops 2,000 for first time since March 1
Positive results from a trial of the COVID-19 vaccine developed by Pfizer and German partner BioNTech in children aged 5…
Read More » - Market
FDA panel recommends Pfizer’s COVID-19 booster for 65 and older, but not for the general public
A group of advisors to the Food and Drug Administration on Friday reframed a proposed approval of BioNTech and Pfizer’s…
Read More » - Market
Scientists continue to say there isn’t enough evidence to support giving COVID-19 boosters to all Americans
The U.S. is days away from President Joe Biden’s target date to begin rolling out COVID-19 booster shots to Americans…
Read More » - Market
COVID-19 booster shots are more complicated than they appear. Here’s why
Not everyone agrees that COVID-19 booster shots are necessary for all vaccinated Americans, and that discord may slow down plans…
Read More » - Market
Vaccine hesitancy falls to lowest level since start of coronavirus pandemic in new poll, but more Americans still need to be persuaded
Fewer American adults than ever say they will not get vaccinated against the coronavirus that causes COVID-19, and more than…
Read More » - Market
U.S. Education Department opens civil-rights probe of school face-mask bans in latest clash between Republican governors and Biden administration
The U.S. Education Department has opened civil-rights investigations of five states that have banned school districts from mandating face masks…
Read More » - Market
FDA approves Pfizer’s COVID-19 shot, making it the first vaccine to receive ‘full’ approval in the U.S.
The U.S. formally approved BioNTech and Pfizer’s COVID-19 vaccine in a move that could sway some of the unvaccinated to…
Read More »